Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

REPLIGEN CORP REPLIGEN CORPORATION
Updated on 07 Aug 2020 (End of trading day)
Last (USD): 152.770 Change: -1.900 High: 157.010 Remarks: -
Change (%): -1.23 Low: 152.000
Open 154.840 Yesterday's Close 154.67000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 462,718 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.40781 Trailing EPS (USD) e 0.58929 NAV (USD) b 20.9519
PE a 374.611 Trailing PE f 259.246 Price / NAV b 7.2915
Dividend (USD) d - Cash In Hand (USD) g 10.6731 Issued & Paid-up Shares c 52,502,600
Dividend Yield (%) d - Price / Cash In Hand g 14.314 Treasury Shares h -
Market Cap (M) 8,020.822 Enterprise Value (M) 7,728.874
Piotroski F Score 7 Exchange Code RGEN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 41.88 Free Float (%) 92.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 31 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference REPLIGEN CORP NASDAQ 8,020.822 374.611 259.246 7.2915 -
Industry Pharmaceuticals: Major NASDAQ 1,688.792 114.250 40.943 2.7332 0.008
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 129,695.484 39.861 10.559 1.8241 2.269
Local Peer ROYALTY PHARMA PLC NASDAQ 26,563.852 11.311 11.311 5.1481 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,244.912 - - 22.9389 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,768.392 6.815 7.746 0.7914 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,479.465 - - - -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,218.912 - - -25.3651 -
Local Peer ALLAKOS INC NASDAQ 4,144.648 - - 8.6700 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 3,889.081 - - - -
Local Peer OPKO HEALTH INC NASDAQ 3,771.149 - - 2.3742 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 3,036.119 - - - -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,356.069 - - 6.1724 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,289.766 - - 6.1585 -
Other Local Peers APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), GENERATION BIO CO (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), PETIQ INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANNEXON INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), AC IMMUNE SA (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), IMARA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), BEYONDSPRING INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), POLYPID LTD (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), GENPREX INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), NOVAN INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), MEDIWOUND LTD (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), BAUDAX BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 391,237.052 25.877 25.765 6.2123 2.523
Global Peer PFIZER INC NYSE 213,583.214 13.126 15.073 3.3198 3.783
Global Peer MERCK & CO INC NYSE 204,919.025 20.819 19.555 7.4133 2.800
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 204,543.945 29.021 28.337 3.8011 2.222
Global Peer ABBVIE INC NYSE 163,988.004 20.911 23.759 11.1496 3.959
Global Peer ELI LILLY AND COMPANY NYSE 146,272.957 31.539 26.036 35.7380 1.689
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 145,426.870 108.485 67.555 11.8842 2.472
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 138,069.344 40.148 - 2.8123 2.711
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,163.878 20.065 19.499 14.6476 1.759
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 102,328.649 17.268 16.005 6.0926 4.782
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), CANSINOBIO-B (HKEx), INNOVENT BIO (HKEx), SINOPHARM (HKEx), SH PHARMA (HKEx), JUNSHI BIO (HKEx), BAIYUNSHAN PH (HKEx), HENLIUS-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), HEPALINK (HKEx), ADC THERAPEUTICS SA (NYSE), CMS (HKEx), AKESO-B (HKEx), HYGEIA HEALTH (HKEx), TRAD CHI MED (HKEx), OCUMENSION-B (HKEx), INNOCARE-B (HKEx), SSY GROUP (HKEx), UNITED LAB (HKEx), CSTONE PHARMA-B (HKEx), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), Kimia Farma Tbk. (IDX), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), HUA MEDICINE-B (HKEx), IMMUNOTECH-B (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), IGBB (Bursa), SHINEWAY PHARM (HKEx), TOT BIOPHARM-B (HKEx), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), PHARMA (Bursa), PYC THERAPEUTICS LIMITED (ASX), LANNETT CO INC (NYSE), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), DAWNRAYS PHARMA (HKEx), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), BIOMX INC (NYSE American), Hyphens Pharma (SGX), Phapros Tbk. (IDX), Merck Tbk. (IDX), KOTRA (Bursa), NEW RAY MEDIC (HKEx), NOVA (Bursa), PAK FAH YEOW (HKEx), PALLA PHARMA LTD (ASX), RACE ONCOLOGY LTD (ASX), BIOHLDG (Bursa), IP (SET), NC HEALTHCARE (HKEx), ONCOSIL MEDICAL LIMITED (ASX), CHARMACY PHAR (HKEx), IMMURON LIMITED (ASX), AGEX THERAPEUTICS INC (NYSE American), NOXOPHARM LTD (ASX), NEP INTERLONG (HKEx), TBG DIAGNOSTICS LTD (ASX), WAI YUEN TONG (HKEx), ANNOVIS BIO INC (NYSE American), INVION LTD (ASX), SANAI HEALTH GP (HKEx), JCT (SET), PURAPHARM (HKEx), MEDLAB CLINICAL LIMITED (ASX), EXTRAWELL PHAR (HKEx), PHARMAXIS (ASX), SUNZEN (Bursa), TIMBER PHARMACEUTICALS INC (NYSE American), PASHUN INT'L (HKEx), EXOPHARM LTD (ASX), ACRUX (ASX), SINOLIFE UTD (HKEx), TALI DIGITAL LIMITED (ASX), CELLMID LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), Pharmesis Intl (SGX), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.860
+1.23 %
10 Days -+18.410
+13.70 %
20 Days -+26.640
+21.12 %
Medium Term Return 3 Months -+29.920
+24.35 %
6 Months -+51.445
+50.77 %
1 Year -+60.930
+66.34 %
Long Term Return 2 Years -+103.500
+210.07 %
3 Years -+111.590
+270.98 %
5 Years -+117.990
+339.25 %
Annualised Return Annualised --
+34.44 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 72.320 - 159.970 Change From 1 Year Low +80.450 % Change From 1 Year Low (%) +111.24
Change From 1 Year High -7.200 % Change From 1 Year High (%) -4.50
2 Years Range 48.260 - 159.970 Change From 2 Years Low +104.510 % Change From 2 Years Low (%) +216.56
Change From 2 Years High -7.200 % Change From 2 Years High (%) -4.50
5 Years Range 20.070 - 159.970 Change From 5 Years Low +132.700 % Change From 5 Years Low (%) +661.19
Change From 5 Years High -7.200 % Change From 5 Years High (%) -4.50
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 154.840 157.010 152.000 152.770 462,718 -
06 Aug 2020 156.960 157.400 151.155 154.670 511,859 -
05 Aug 2020 157.000 158.010 154.770 155.880 360,257 -
04 Aug 2020 157.710 158.130 154.150 156.540 513,845 -
03 Aug 2020 152.460 159.970 152.460 158.270 647,261 -
31 Jul 2020 152.000 154.500 146.800 150.910 1,054,203 -
30 Jul 2020 143.130 155.270 142.544 151.250 852,880 -
29 Jul 2020 137.300 140.190 137.150 138.780 468,576 -
28 Jul 2020 138.170 139.650 136.730 137.070 295,840 -
27 Jul 2020 135.660 138.020 135.230 137.630 220,865 -
24 Jul 2020 134.530 135.220 131.910 134.360 375,689 -
23 Jul 2020 136.910 141.120 135.835 136.730 495,593 -
22 Jul 2020 135.990 137.736 134.150 135.880 437,253 -
21 Jul 2020 136.620 136.620 133.760 134.990 258,253 -
20 Jul 2020 134.720 138.385 134.630 136.040 337,673 -
17 Jul 2020 132.710 135.172 131.950 134.310 271,525 -
16 Jul 2020 131.030 132.900 129.750 131.940 442,152 -
15 Jul 2020 125.370 131.230 125.250 130.970 589,839 -
14 Jul 2020 122.890 124.930 120.123 124.840 397,778 -
13 Jul 2020 126.180 129.495 122.430 122.510 278,241 -
10 Jul 2020 128.760 129.070 125.850 126.130 242,350 -
09 Jul 2020 125.910 129.930 125.570 128.670 438,263 -
Summary
Current 2 Weeks
(27 Jul 2020 to 07 Aug 2020)
135.660 159.970 135.230 152.770 5,388,304 -
Previous 2 Weeks
(13 Jul 2020 to 24 Jul 2020)
126.180 159.970 122.430 134.360 3,883,996 -
4 Weeks from
(12 Jun 2020 to 10 Jul 2020)
116.220 159.970 114.360 126.130 18,968,904 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.